Wolverine Asset Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Wolverine Asset Management’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-90,366	Closed	-$3.4M	–	2640
2021 Q1	$3.4M	Buy	+90,366	New	+$2.25M	0.03%	315

Wolverine Asset Management's FPRX Position: Q2 2021 in Review

Wolverine Asset Management sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 90,366 shares — an estimated $3.4M sold.

Wolverine Asset Management first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $3.4M in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

Wolverine Asset Management reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
Wolverine Asset Management sold 90,366 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $3.4M.
Wolverine Asset Management first reported a position in Five Prime Therapeutics, Inc. in Q1 2021 and held it in 1 quarter.
Wolverine Asset Management's Five Prime Therapeutics, Inc. position peaked at $3.4M in Q1 2021.
0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Wolverine Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.